What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of KRM Ayurveda Limited IPO?

KRM Ayurveda Limited IPO has received a total subscription of 74.43 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

KRM Ayurveda Limited

ListedSME

Healthcare Sector · NSE

Incorporated on 3 September 2019, KRM Ayurveda Ltd operates a network of hospitals and clinics across several cities in India and has also expanded its presence internationally through telemedicine consultations and online sales. The company is engaged in manufacturing Ayurvedic products, including herbal and botanical remedies, medicines, supplements, and wellness or skincare-related items. Currently, it manages six hospitals and five clinics at different locations in the country, offers teleconsultation services, and sells KRM Ayurveda products, with a total workforce of 429 employees across various departments as of August 31, 2025.

Price Band

₹128 – ₹135

Issue Size

₹77.49 Cr

Lot Size

1000 shares

GMP

₹17

+12.6%

Est. Listing

₹152

at current GMP

Subscribed

74.43x

overall

Open

21 Jan 2026

23 Jan 2026

Allotment

27 Jan 2026

Refund

28 Jan 2026

Demat Credit

29 Jan 2026

Listing

29 Jan 2026

Last updated 9 months ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

74.43x

Total Demand

QIB Multiplier

63.31x

Institutions & Funds

NII / HNI

136.10x

High Net-Worth

Retail (RII)

54.21x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 74.43x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
QIB	1,032,000	65,338,000	63.31x
NIB	780,000	106,159,000	136.10x
HNIs(10L +)	520,000	87,169,000	167.63x
HNIs (2-10L)	260,000	18,990,000	73.04x
RETAIL	1,812,000	98,222,000	54.21x
Total	4,404,000	375,878,000	74.43x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Apps 70.71x

Category	Applications Reserved	Applications Received	Times Subscribed
QIB	—	58	0.00x
NIB	—	16,637	0.00x
RETAIL	906	49,111	54.21x
HNIs(10L +)	173	10,615	61.36x
HNIs (2-10L)	87	6,022	69.22x
Total Applications	1,166	82,443	70.71x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About KRM Ayurveda Limited Public Issue & Market Profile

KRM Ayurveda Limited is bringing an initial public offering (IPO) in the Healthcare Sector sector with an aggregate issue size of ₹77.49 Crores. The shares are offered at a price band of ₹128 to ₹135 per equity share on NSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.

Bidding & Quota Instructions:

The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.

Allotment Reconciliation Schedule:

Following the close of bidding on 2026-01-23, the basis of allotment is scheduled to be finalized on 2026-01-27. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Skyline Financial Services Private Limited) or the BSE allotment checking window.

Frequently Asked Questions

What is KRM Ayurveda Limited IPO GMP today?

The latest Grey Market Premium (GMP) for KRM Ayurveda Limited IPO is ₹17 per equity share. Based on the upper price band of ₹128 to ₹135 per equity share, the estimated listing price is ₹152 (+12.6% expected listing gain).

What is the expected profit per lot for KRM Ayurveda Limited IPO?

With a lot size of 1000 shares and current GMP of ₹17, the expected profit per application lot is approx ₹17,000 (+12.6% gain). Minimum application cost is approx ₹1,35,000.

What is the issue size and price band for KRM Ayurveda Limited IPO?

The KRM Ayurveda Limited IPO aggregate issue size is ₹77.49 Crores with an equity price band set at ₹128 to ₹135 per equity share. The retail lot size is 1000 shares requiring a minimum capital outlay of approx. ₹1,35,000.

How can I check KRM Ayurveda Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 74.43x (Retail: 54.21x, QIB: 63.31x, NII: 136.10x). You can track live multiples directly on our dedicated subscription page.

Where and when will KRM Ayurveda Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Skyline Financial Services Private Limited) and the BSE status verification website on or around 2026-01-27. Investors can verify status using PAN card or application number.

When is the listing date for KRM Ayurveda Limited IPO?

KRM Ayurveda Limited shares are scheduled to list on NSE on 2026-01-29.